参考文献/References:
[1] GOSSIEL F,PAGGIOSI M A,NAYLOR K E,et al.The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis:the T-score bone marker approach in the TRIO study[J].Bone,2020,131:115158.
[2] SI L,WINZENBERG T M,JIANG Q,et al.Projection of osteoporosis-related fractures and costs in China:2010-2050[J].Osteoporos Int,2015,26(7):1929-1937.
[3] HURTADO-NAVARRO I,GARCÍA-SEMPERE A,RODRÍGUEZ-BERNAL C,et al.Impact of drug safety warnings and cost-sharing policies on osteoporosis drug utilization in Spain:a major reduction but with the persistence of over and underuse.Data from the ESOSVAL cohort from 2009 to 2015[J].Front pharmacol,2019,10:768.
[4] 刘魏,童培建,肖鲁伟,等.益骨汤口服联合太极拳锻炼治疗老年性骨质疏松症肾阳虚证[J].中医正骨,2018,30(11):6-12.
[5] 王伟,万雷,柴爽,等.骨质疏松症的中医病因病机和分期治疗[J].中医正骨,2018,30(2):29-30.
[6] 陈娟,谢丽华,李生强,等.绝经后骨质疏松症肾阴虚证关联基因CLCF1 mRNA的表达研究[J].中国骨质疏松杂志,2014,20(6):618-622.
[7] 邓昶,周明旺,付志斌,等.骨质疏松症的中医病因病机及其治疗进展[J].中国骨质疏松杂志,2017,23(8):1105-1111.
[8] 王颖颖,郭凯波.六味地黄丸(汤)拆方研究进展[J].浙江中西医结合杂志,2017,27(4):349-352.
[9] ZHU Y,WANG Y M,JIA Y C,et al.Catalpol promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the Wnt/β-catenin pathway[J].Stem Cell Res Ther,2019,10(1):37.
[10] MENG J,ZHANG W,WANG C,et al.Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity[J].Biochem pharmacol,2020,171:113715.
[11] 黄佳纯,林燕平,陈桐莹,等.山茱萸新苷Ⅰ对成骨细胞的增殖及成骨分化的影响[J].中国骨质疏松杂志,2020,26(1):1-5.
[12] LEE S,CHOI E,YANG S M,et al.Bioactive compounds from sclerotia extract of Poria cocos that control adipocyte and osteoblast differentiation[J].Bioorg Chem,2018,81:27-34.
[13] 梁博程,史晓林,许超,等.基于中药系统药理学方法研究六味地黄丸治疗骨质疏松症的药效成分、作用靶点及作用特点[J].中医正骨,2019,31(4):1-7.
[14] 李玉星.基于OPG和RANKL探讨六味地黄汤及其“补泻”药对干预绝经后骨质疏松模型大鼠的作用及其机制[D].长沙:湖南中医药大学,2018.
[15] 陈娟,谢丽华,李生强,等.JAK/STAT通路介导的六味地黄丸对绝经后骨质疏松症肾阴虚证的免疫调节作用[J].中华中医药杂志,2017,32(4):1747-1750.
[16] XIA B J,XU B,SUN Y,et al.The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis[J].J Ethnopharmacol,2014,153(1):133-141.
[17] 宫蕊.六味地黄丸干预绝经后骨质疏松与骨质疏松相关疾病基因表达生物信息学分析研究[D].石家庄:河北医科大学,2019.
[18] 卢严方,林贯川,刘倩倩,等.六味地黄丸对绝经期肾阴虚骨质疏松症的基因表达调控数据分析[J].中国骨质疏松杂志,2017,23(3):350-356.
[19] 宋明,陈家旭,刘玥芸,等.论蛋白质组学与中医证候研究[J].中华中医药杂志,2017,32(11):4804-4807.
[20] 郭洁梅,黄露露,赖兴泉.六味地黄丸对肾阴虚证大鼠股骨髁松质骨差异蛋白质表达的影响[J].中华中医药杂志,2019,34(1):81-85.
[21] 方虹,鲁林,陈炜.经皮雌二醇联合六味地黄丸治疗绝经期妇女骨质疏松症临床研究[J].湖北中医药大学学报,2019,21(5):28-31.
[22] 王玺,罗志秀.六味地黄丸联合鲑鱼降钙素对改善绝经后骨质疏松性疼痛症状的临床研究[J].中国骨质疏松杂志,2018,24(11):1485-1488.
[23] 王久清,张显,郭庆功,等.阿仑膦酸钠片联合六味地黄丸治疗女性绝经后骨质疏松症40例临床观察[J].中国民族民间医药,2018,27(20):74-76.
[24] 蔡玉霞,张剑宇.补骨脂水煎剂对去卵巢骨质疏松大鼠骨代谢的影响[J].中国组织工程研究与临床康复,2009,13(2):268-271.
[25] 梁秋峰,曹云桂,陈奇.六味地黄丸治疗卵巢早衰的研究进展[J].医学综述,2019,25(17):3508-3512.
[26] 杜丹,魏洁玲,陈妙云.六味地黄丸联合激素替代治疗卵巢早衰的临床研究[J].中华中医药学刊,2013,31(12):2738-2740.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(04):12.
[3]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[4]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(04):27.
[5]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(04):19.
[6]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(04):20.
[7]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(04):5.
[8]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(04):21.
[9]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(04):16.
[10]许超,肖鲁伟,吴承亮.绝经后女性骨质疏松症辨证分型与抑郁焦虑的关系研究[J].中医正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(04):3.
[11]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(04):7.
[12]欧国峰,刘鑫,董博,等.绝经后骨质疏松症的免疫学研究进展[J].中医正骨,2016,28(08):70.
[13]施振宇,刘钟,陈文亮,等.中医综合疗法防治绝经后骨量减少的多中心临床研究[J].中医正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(04):1.
[14]梁文娜,李西海,李灿东.血清microRNA与绝经后骨质疏松症肾虚证的关系[J].中医正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J].中医正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(04):1.
[16]刘晨,李兴勇,姚兴璋,等.绝经后骨质疏松症的流行病学概况及发病机制研究进展[J].中医正骨,2018,30(03):52.
[17]杨依然,刘钟,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白通路参与绝经后骨质疏松症发生发展过程中细胞自噬的机制[J].中医正骨,2018,30(04):59.
[18]曹俊青,郑剑南,张麟.右归丸联合阿仑膦酸钠口服治疗绝经后骨质疏松症肾阳虚证的临床研究[J].中医正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右归丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(04):20.
[19]李中万,徐绍俊,杨广钢,等.健肾方联合碳酸钙D3咀嚼片(Ⅱ)
治疗绝经后骨质疏松症肾阳虚证[J].中医正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健肾方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(04):11.
[20]赵凡,刘全,吴连国.口服强骨饮联合碳酸钙D3片治疗绝经后骨质疏松症的临床研究[J].中医正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(强骨饮)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(04):26.